the Catholic University of Korea St. Vincent's Hospital
Suwon, 16247, South Korea
Location status: Recruiting
NCT Number: NCT02920554
The extent of hepatic resection for gallbladder cancer can be done from a wedge resection to 4b/5 bisegmentectomy. This study aims to compare the recurrence rates and survival rates between wedge resection group and bisegmentectomy group. Patients with T2 or T3 gallbladder cancer on preoperative CT exam or patients who were pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy were enrolled. All patients are randomly assigned to wedge resection or bisegmentectomy group. Number of patients in each group is 44. Primary endpoint is recurrence-free-survival rates and overall survival rates.
Interested in participating?
Request Info19 year–80 year
All sexes
Interventional
Not applicable
Suwon, 16247, South Korea
Location status: Recruiting
The extent of hepatic resection for gallbladder cancer has a wide range. A partial hepatectomy involving the gallbladder fossa is a critical part of the resection but can range from a wedge resection to an anatomic resection of segments 4b and 5 to an extended right hepatectomy. This study enrolls Patients with T2 or T3 gallbladder cancer on preoperative CT exam or patients who were pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy. Eighty eight patients are randomized to wedge resection group or bisegmentectomy group. Except the extent of hepatic resection, all the procedures including hepatoduodenal,common hepatic, posterior pancreatic lymph node dissection are same.
Primary endpoint is recurrence-free-survival rates and overall survival rates.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The extent of hepatic resection is wedge resection of liver including gallbladder fossa
The extent of hepatic resection is 4b/5 bisegmentectomy of liver
Time frame: 1 year
3year 5 year
Contact information is provided by the study sponsor or research team.
Dong Do You, MD, PhD
CONTACT
Kwang Yeol Paik, MD, PhD
CONTACT
Saint Vincent's Hospital, Korea
Other
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer Operation: Prospective Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02012699
Abdominal Neoplasms, Adenoma
Greenwood Village, Colorado, United States
View Trial DetailsNCT07614061
Adenocarcinoma, Biliary Tract Diseases
Shanghai, China
View Trial DetailsNCT04907643
Adenocarcinoma, Ampullary Cancer
Los Angeles, California, United States
View Trial DetailsNCT07146646
Adenocarcinoma, Biliary Tract Cancer
Cleveland, Ohio, United States
View Trial Details